text
"['\n3. 원재료 및 생산설비\n1. 주요 원재료 (연결기준)\n(단위 : 백만원, %)\n사업부문\n매입유형\n품 \xa0 목\n구체적용도\n매입액\n매입비중\n양약\n원재료\nCefazedone Acid\n제노세프주\n1,080\n9.58%\nVC-VSTANCRUD\n암로발탄정\n918\n8.14%\nSulbactam Acid\n박타신주\n746\n6.62%\nPiperacillin Sod - Tazobactam 8:1\n린박탐주\n479\n4.25%\nClavulanate Potassium 외\n-\n7,126\n63.22%\n<국내사업 부분 소계>\n-\n10,348\n91.82%\n<해외사업 부분 소계>\n바루세파주 외\n922\n8.18%\n총 \xa0 \xa0계\n-\n11,271\n100.00%\n상품\n원료상품\n알벤다졸외\n원료수출 외\n717\n13.98%\n2. 주요원재료의 가격변동 추이\n(단위 : 원)\n품 목\n제38기 1분기\n제37기\n제36기\nCefazedone Acid (KG)\n270,000\n270,000\n270,000\nCeftezole Free Acid (KG)\n197,284\n197,284\n197,284\nEzetimibe (KG)\n2,496,486\n2,446,667\n2,600,000\nRosuvastatin Calcium (KG)\n2,500,000\n2,500,000\n2,700,000\nPiperacillin Sod - Tazobactam 8:1 (KG)\n295,000\n278,290\n260,000\n3. 생산 및 설비 현황(1) 생산능력, 생산실적, 가동률에 관한 사항1) 생산능력\r\n(단위 : 백만원)\n사업부문\n품 목\n사업소\n제38기 1분기\n제37기 1분기\n제37기\n금액\n금액\n금액\n제조\n캅셀,정제등\n안산\n34,002\n27,850\n115,719\n(2) 생산능력의 산출근거\n1) 산출기준\n(단위 : 백만원)\n구분\n생산기종\n보유대수\n일일생산능력\n당기간작업일수\n당기간생산능력\n비고\n정제\n타정기\n16\n24.4\n62\n24,241\n-\n캡슐제\n캡슐충전기\n2\n52.1\n62\n6,455\n-\n앰플주사제\n앰플충전기\n1\n16.6\n62\n1,030\n-\n과렙제\n과립충전기\n1\n14.6\n62\n905\n-\n분말주사제\n분말충전기\n4\n3.6\n62\n883\n-\n바이알주사제\n바이알충전기\n1\n4.5\n62\n279\n-\n기타\n기타\n91\n0.0\n62\n208\n-\n2) 산출방법: 생산기보유대수 X 일일생산능력 X 당기간작업일수 = 당기간생산능력\n3) 평균가동시간\n구분 \xa0 / \xa0 사업소\n안산공장\n일일평균가동시간\n8\n월평균가동시간\n165\n당기간가동일수\n62\n당기간가동시간\n496\n4) 생산실적\n(단위 : 백만원)\n사업부문\n품 목\n사업소\n제38기 제1분기\n제37기 제1분기\n제37기\n금액\n금액\n금액\n제조\n캅셀,정제외\n안산공장\n25,964\n20,400\n104,632\n5) 당해 연간 가동률\n(단위 : 시간, %)\n사업소(사업부문)\n당기간 가동가능시간\n당기간 실제가동시간\n평균가동률\n제조(안산공장)\n캅셀, 정제외\n496\n379\n76.4\n(3) 설비에 관한 사항\n(단위 : 백만원)\n소재지\n구분\n기초장부가액\n증가\n감소\n당기상각\n외환차이\n당기말장부가액\n비고\n안산시\n토지\n2,267\n-\n-\n-\n-\n2,267\n27,154㎡\n안양연구소\n1,193\n-\n-\n-\n-\n1,193\n51,984㎡\n오송생명과학단지\n7,433\n-\n-\n-\n-\n7,433\n역삼동 외\n5,083\n-\n-\n-\n-\n5,083\n1,522㎡\n소계\n15,976\n15,976\n80,660㎡\n안산시\n건물\n27,114\n-\n-\n243\n-\n26,871\n25,575㎡\n안양연구소\n2,072\n-\n-\n19\n-\n2,053\n5,418㎡\n오송공장\n21,444\n-\n-\n179\n-\n21,265\n3,288㎡\n오송(기숙사)\n441\n-\n-\n4\n-\n437\n역삼동 외\n2,546\n-\n-\n30\n-\n2,516\n3,288㎡\n베트남\n769\n-\n-\n23\n25\n771\n소계\n54,386\n-\n-\n498\n25\n53,913\n34,281㎡\n안산시\n건물부속설비\n13,670\n238\n-\n410\n-\n13,498\n오송공장\n258\n-\n-\n6\n-\n252\n안양연구소\n151\n-\n-\n4\n-\n147\n역삼동 외\n82\n-\n-\n1\n-\n81\n소계\n14,161\n238\n-\n421\n-\n13,978\n안산시\n구축물\n205\n-\n-\n9\n-\n196\n오송공장\n1,161\n-\n-\n25\n-\n1,136\n소계\n1,366\n-\n-\n34\n-\n1,332\n안산시\n기계장치\n18,187\n654\n-\n934\n-\n17,907\n오송공장\n302\n-\n-\n259\n-\n43\n베트남\n1,869\n9\n-\n101\n85\n1,862\n소계\n20,358\n663\n-\n1,294\n85\n19,812\n안산시\n차량운반구\n48\n-\n-\n4\n-\n44\n역삼동 외\n51\n-\n-\n5\n-\n46\n베트남\n158\n-\n-\n7\n5\n156\n미얀마\n14\n-\n12\n-\n-\n2\n필리핀\n13\n-\n-\n2\n-\n12\nUSA\n-\n-\n-\n-\n-\n-\n소계\n284\n-\n12\n18\n5\n260\n안산시\n공기구비품\n652\n88\n-\n74\n-\n666\n오송공장\n9\n-\n-\n1\n-\n8\n안양연구소\n57\n9\n-\n16\n-\n50\n역삼동 외\n64\n-\n-\n7\n-\n57\n베트남\n5\n-\n-\n-\n-\n5\n미얀마\n6\n1\n-\n-\n-\n7\n소계\n792\n98\n-\n98\n-\n792\n안산시 외\n건설중인자산\n4,230\n2,238\n-\n-\n-\n6,468\n베트남\n건설중인자산\n-\n-\n-\n-\n-\n-\n소계\n4,230\n2,238\n-\n-\n-\n6,468\n안산시\n미착기계\n-\n-\n-\n-\n-\n-\n소계\n-\n-\n-\n-\n-\n-\n안산시 외\n사용권자산\n1,913\n70\n-\n392\n-\n1,591\n베트남\n294\n-\n-\n3\n10\n301\n소계\n2,207\n70\n-\n395\n10\n1,892\n합계\n113,759\n3,307\n12\n2,758\n125\n114,421\n(4) 중요한 시설투자 계획공시서류작성일 현재 회사의 중요한 시설투자 계획은 없습니다. \n']"
